Corticosteroids

Elephant in the room
Daniel M Hartung, Kirbee Johnston, David M Cohen, Thuan Nguyen, Atul A Deodhar, Dennis N Bourdette

Annals of the Rheumatic Diseases Feb 2019, 78 (2) e11; DOI: 10.1136/annrheumdis-2018-213008
Response to: ‘Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis’ by Lee and Song
Yoshikazu Nakaoka

Annals of the Rheumatic Diseases Jan 2019, 78 (1) e10; DOI: 10.1136/annrheumdis-2017-212871
Predictive factors of pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids
Julia Herrou, Victoire De Lastours

Annals of the Rheumatic Diseases Nov 2018, annrheumdis-2018-214718; DOI: 10.1136/annrheumdis-2018-214718
Some concerns from Turkey
Emre Bilgin, İrem Ozarli, Levent Kılıç, Ertuğrul Çağrı Bölek, Gözde Kübra Yardımcı, Ömer Karadağ

Annals of the Rheumatic Diseases Nov 2018, annrheumdis-2018-214739; DOI: 10.1136/annrheumdis-2018-214739
Incidence, prevalence and treatment burden of polymyalgia rheumatica in the UK over two decades: a population-based study
Richard James Partington, Sara Muller, Toby Helliwell, Christian D Mallen, Alyshah Abdul Sultan

Annals of the Rheumatic Diseases Dec 2018, 77 (12) 1750-1756; DOI: 10.1136/annrheumdis-2018-213883
Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis
Mascha Koenen, Stephan Culemann, Sabine Vettorazzi, Giorgio Caratti, Lucien Frappart, Wolfgang Baum, Gerhard Krönke, Ulrike Baschant, Jan P Tuckermann

Annals of the Rheumatic Diseases Nov 2018, 77 (11) 1610-1618; DOI: 10.1136/annrheumdis-2017-212762
Response to: ‘Aortic ulceration in a tocilizumab-treated patient with Takayasu arteritis’ by Liebling et al
Yoshikazu Nakaoka

Annals of the Rheumatic Diseases Oct 2018, annrheumdis-2018-214239; DOI: 10.1136/annrheumdis-2018-214239
Response to: ‘Checkpoint inhibitors and arthritis: seeking balance between victories and defeats’ by Moura and Moura
Thierry Schaeverbeke, Marie Kostine

Annals of the Rheumatic Diseases Aug 2018, annrheumdis-2018-213906; DOI: 10.1136/annrheumdis-2018-213906
Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire
Joanna C Robson, Jill Dawson, Helen Doll, Peter F Cronholm, Nataliya Milman, Katherine Kellom, Susan Ashdown, Ebony Easley, Don Gebhart, Georgia Lanier, John Mills, Jacqueline Peck, Raashid Ahmed Luqmani, Judy Shea, Gunnar Tomasson, Peter A Merkel

Annals of the Rheumatic Diseases Aug 2018, 77 (8) 1157-1164; DOI: 10.1136/annrheumdis-2017-212713
Ability of disease-modifying antirheumatic drugs to prevent or delay rheumatoid arthritis onset: a systematic literature review and meta-analysis
Stéphane Hilliquin, Benjamin Hugues, Stéphane Mitrovic, Laure Gossec, Bruno Fautrel

Annals of the Rheumatic Diseases Aug 2018, 77 (8) 1099-1106; DOI: 10.1136/annrheumdis-2017-212612

Main menu

Corticosteroids

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Corticosteroids

Pages